| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_046b94174ff188b5b5d0c4605583ee11 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D209-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D209-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Y305-01098
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-404 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D277-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-428
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D277-82 |
| filingDate |
2012-06-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b1e98141e4fd9f44412294604e9f0692
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_57e6b84acbbca546b54d847f82e5e2dd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7f5977adb83be3aab976d24bcd5b8cf9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_080136fd12582dc529432cbf23fdd098
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ce6d272525ee4b8cde1fb2f029d83c2e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a6ab99e78514742c23766bdc55f2f643
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9a870ec6738f764b4a6b24bab7cd12fe |
| publicationDate |
2013-12-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
KR-20130143344-A |
| titleOfInvention |
Novel hydroxamic acid having histone deacetylase inhibitory activity and an anticancer composition comprising the same as an active ingredient |
| abstract |
The present invention relates to a novel hydroxamic acid compound and an anticancer pharmaceutical composition comprising the same as an active ingredient. The hydroxamic acid compound of the present invention has an inhibitory activity of histone deacetylase (HDAC), exhibits cytotoxicity in various cancer cells, and exhibits anticancer efficacy, and thus can be usefully used as a powerful anticancer agent. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2015016441-A1 |
| priorityDate |
2012-06-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |